Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Adrenal Function
100%
Oral Corticosteroids
100%
Functional Recovery
100%
Benralizumab
100%
Corticosteroid-sparing
100%
Corticosteroids
66%
Maintenance Phase
50%
Asthma Control
33%
Adverse Events
33%
Daily Dose
33%
Asthma Exacerbation
33%
Adrenal Insufficiency
33%
Median Range
33%
Asthma Control Questionnaire
33%
St. George's Respiratory Questionnaire
33%
Adverse Outcomes
16%
Quality of Life Improvement
16%
1-median
16%
Severe Eosinophilic Asthma
16%
Corticosteroid Dependence
16%
Medicine and Dentistry
Adrenal Function
100%
Benralizumab
100%
Corticosteroid
100%
Oral
100%
Asthma
30%
Asthma Exacerbation
20%
Adrenal Insufficiency
20%
Asthma Control Questionnaire
20%
St. George Respiratory Questionnaire
20%
Adverse Event
20%
Adverse Outcome
10%
Quality of Life
10%
Eosinophilic
10%
Deterioration
10%
Drug Dose Increase
10%
Immunology and Microbiology
Asthma
100%
Benralizumab
100%
Adrenal Function
100%
Asthma Exacerbation
40%
Drug Dose Increase
20%
Pharmacology, Toxicology and Pharmaceutical Science
Benralizumab
100%
Corticosteroid
100%
Asthma
60%
Adverse Event
20%
Adrenal Insufficiency
20%
Adverse Outcome
10%
Asthmatic State
10%
Deterioration
10%